Alternative splicing of IRF3 plays an important role in the development of hepatocarcinoma
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alternative splicing of IRF3 plays an important role in the development of hepatocarcinoma
Authors
Keywords
-
Journal
Epigenetics
Volume 18, Issue 1, Pages -
Publisher
Informa UK Limited
Online
2023-11-06
DOI
10.1080/15592294.2023.2276371
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ASF1B Serves as a Potential Therapeutic Target by Influencing Cell Cycle and Proliferation in Hepatocellular Carcinoma
- (2022) Xiaoxi Ouyang et al. Frontiers in Oncology
- Rcl1 suppresses tumor progression of hepatocellular carcinoma: a comprehensive analysis of bioinformatics and in vitro experiments
- (2022) Yu Jiaze et al. Cancer Cell International
- LINC02154 promotes the proliferation and metastasis of hepatocellular carcinoma by enhancing SPC24 promoter activity and activating the PI3K-AKT signaling pathway
- (2022) Huan Yue et al. CELLULAR ONCOLOGY
- Targeted exon skipping of NF1 exon 17 as a therapeutic for neurofibromatosis type I
- (2022) André Leier et al. Molecular Therapy-Nucleic Acids
- Comprehensive analysis of prognosis-related alternative splicing events in ovarian cancer
- (2022) Shizhi Wang et al. RNA Biology
- LncRNA CRNDE attenuates chemoresistance in gastric cancer via SRSF6-regulated alternative splicing of PICALM
- (2021) Feifei Zhang et al. Molecular Cancer
- The tumor microenvironment impairs Th1 IFNγ secretion through alternative splicing modifications of Irf1 pre-mRNA
- (2021) Antoine Bernard et al. Cancer Immunology Research
- Hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Disease Primers
- Analysis of m6A RNA Methylation-Related Genes in Liver Hepatocellular Carcinoma and Their Correlation with Survival
- (2021) Yong Li et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The footprint of kynurenine pathway in every cancer: a new target for chemotherapy
- (2021) Moein Ala EUROPEAN JOURNAL OF PHARMACOLOGY
- Identification of prognostic alternative splicing events related to the immune microenvironment of hepatocellular carcinoma
- (2021) Shanshan Yu et al. MOLECULAR MEDICINE
- TCF19 and p53 regulate transcription of TIGAR and SCO2 in HCC for mitochondrial energy metabolism and stress adaptation
- (2021) Payel Mondal et al. FASEB JOURNAL
- Taurine Upregulates miRNA-122-5p Expression and Suppresses the Metabolizing Enzymes of Glycolytic Pathway in Hepatocellular Carcinoma
- (2021) Asmaa Abdel Nabi et al. MOLECULAR BIOLOGY REPORTS
- PCBP1 regulates the transcription and alternative splicing of metastasis‑related genes and pathways in hepatocellular carcinoma
- (2021) Shuai Huang et al. Scientific Reports
- Type IIA topoisomerase (TOP2A) triggers epithelial-mesenchymal transition and facilitates HCC progression by regulating Snail expression
- (2021) Yinying Dong et al. Bioengineered
- Identification and validation of immune-related lncRNA prognostic signature for breast cancer
- (2020) Yong Shen et al. GENOMICS
- Identification of ALDH6A1 as a Potential Molecular Signature in Hepatocellular Carcinoma via Quantitative Profiling of the Mitochondrial Proteome
- (2020) Heon Shin et al. JOURNAL OF PROTEOME RESEARCH
- MTR4 drives liver tumorigenesis by promoting cancer metabolic switch through alternative splicing
- (2020) Lili Yu et al. Nature Communications
- The lncRNA lincNMR regulates nucleotide metabolism via a YBX1 - RRM2 axis in cancer
- (2020) Minakshi Gandhi et al. Nature Communications
- Alternative Splicing in Hepatocellular Carcinoma
- (2020) Seung Eun Lee et al. Cellular and Molecular Gastroenterology and Hepatology
- A Novel Blood-based Panel of Methylated DNA and Protein Markers for Detection of Early-Stage Hepatocellular Carcinoma
- (2020) Naga P. Chalasani et al. Clinical Gastroenterology and Hepatology
- IFN Regulatory Factor 3 in Health and Disease
- (2020) Thomas M. Petro JOURNAL OF IMMUNOLOGY
- Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma
- (2020) Simmone D'souza et al. WORLD JOURNAL OF GASTROENTEROLOGY
- hTFtarget: A Comprehensive Database for Regulations of Human Transcription Factors and Their Targets
- (2020) Qiong Zhang et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage
- (2019) Ping Luo et al. PATHOLOGY & ONCOLOGY RESEARCH
- TPX2 silencing exerts anti‑tumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway
- (2019) Dan‑Hong Huang et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- TCF19 Promotes Cell Proliferation through Binding to the Histone H3K4me3 Mark
- (2019) Payel Mondal et al. BIOCHEMISTRY
- Interferon-Independent Innate Responses to Cytomegalovirus
- (2019) Caroline L. Ashley et al. Frontiers in Immunology
- Cytosolic sensing of immuno-stimulatory DNA, the enemy within
- (2018) Rekha Dhanwani et al. CURRENT OPINION IN IMMUNOLOGY
- Alternative Splicing as a Target for Cancer Treatment
- (2018) Nancy Martinez-Montiel et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- DNA-binding landscape of IRF3, IRF5 and IRF7 dimers: implications for dimer-specific gene regulation
- (2018) Kellen K Andrilenas et al. NUCLEIC ACIDS RESEARCH
- DDX39 promotes hepatocellular carcinoma growth and metastasis through activating Wnt/β-catenin pathway
- (2018) Tong Zhang et al. Cell Death & Disease
- The MBNL3 splicing factor promotes hepatocellular carcinoma by increasing PXN expression through the alternative splicing of lncRNA-PXN-AS1
- (2017) Ji-hang Yuan et al. NATURE CELL BIOLOGY
- Global profiling of alternative RNA splicing events provides insights into molecular differences between various types of hepatocellular carcinoma
- (2016) Marie-Pier Tremblay et al. BMC GENOMICS
- Structural basis for concerted recruitment and activation of IRF-3 by innate immune adaptor proteins
- (2016) Baoyu Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation
- (2015) S. Liu et al. SCIENCE
- Hallmarks of alternative splicing in cancer
- (2013) S Oltean et al. ONCOGENE
- Cyclin-dependent kinase inhibitor 3 is overexpressed in hepatocellular carcinoma and promotes tumor cell proliferation
- (2012) Chunyang Xing et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Identification of novel alternative splicing variants of interferon regulatory factor 3
- (2011) Yong Li et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- ShRNA-Targeted Centromere Protein A Inhibits Hepatocellular Carcinoma Growth
- (2011) Yongmei Li et al. PLoS One
- Positive Regulation of Interferon Regulatory Factor 3 Activation by Herc5 via ISG15 Modification
- (2010) H. X. Shi et al. MOLECULAR AND CELLULAR BIOLOGY
- Alternative isoform regulation in human tissue transcriptomes
- (2008) Eric T. Wang et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now